Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain.

Background: Intravenous (IV) ketamine is used for chronic neuropathic pain refractory to other treatments. Administration of such a medication requires high-cost services while the result is not always satisfactory with a significant percentage of failure. Success and failure are related to some factors.